Affinity Reagent News and Research

RSS
Using synthetic peptides for inflammatory disease diagnosis

Using synthetic peptides for inflammatory disease diagnosis

Lateral flow assays: The possibilities beyond COVID-19

Lateral flow assays: The possibilities beyond COVID-19

MIP Diagnostics secures £7.3M investment following achievement of critical milestones

MIP Diagnostics secures £7.3M investment following achievement of critical milestones

MIP Diagnostics to support the development of challenging affinity reagents with new Molecular Imprinting Epitope Discovery

MIP Diagnostics to support the development of challenging affinity reagents with new Molecular Imprinting Epitope Discovery

DNA synbodies, a new class of affinity reagents, gets major NIH boost

DNA synbodies, a new class of affinity reagents, gets major NIH boost

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.